Beta secretase 1-dependent amyloid precursor protein processing promotes excessive vascular sprouting through NOTCH3 signalling. by Durrant, Claire S et al.
Durrant et al. Cell Death and Disease           (2020) 11:98 
https://doi.org/10.1038/s41419-020-2288-4 Cell Death & Disease
ART ICLE Open Ac ce s s
Beta secretase 1-dependent amyloid precursor
protein processing promotes excessive vascular
sprouting through NOTCH3 signalling
Claire S. Durrant 1,2,3, Karsten Ruscher4,5, Olivia Sheppard1, Michael P. Coleman1,2,6 and Ilknur Özen 1,5,7
Abstract
Amyloid beta peptides (Aβ) proteins play a key role in vascular pathology in Alzheimer’s Disease (AD) including
impairment of the blood–brain barrier and aberrant angiogenesis. Although previous work has demonstrated a pro-
angiogenic role of Aβ, the exact mechanisms by which amyloid precursor protein (APP) processing and endothelial
angiogenic signalling cascades interact in AD remain a largely unsolved problem. Here, we report that increased
endothelial sprouting in human-APP transgenic mouse (TgCRND8) tissue is dependent on β-secretase (BACE1)
processing of APP. Higher levels of Aβ processing in TgCRND8 tissue coincides with decreased NOTCH3/
JAG1 signalling, overproduction of endothelial ﬁlopodia and increased numbers of vascular pericytes. Using a novel
in vitro approach to study sprouting angiogenesis in TgCRND8 organotypic brain slice cultures (OBSCs), we ﬁnd that
BACE1 inhibition normalises excessive endothelial ﬁlopodia formation and restores NOTCH3 signalling. These data
present the ﬁrst evidence for the potential of BACE1 inhibition as an effective therapeutic target for aberrant
angiogenesis in AD.
Introduction
Alzheimer’s disease (AD) is closely associated with
alterations in the vascular system1. Multiple studies in
humans and animal models have described pathological
vascular changes in AD2, including disruption to the
neurovascular unit3 and blood–brain barrier4, increased
microvessel density3,5,6, arteriolar and venular tortuos-
ity7,8 and vascular Aβ accumulation9. Such changes will
likely compromise the effective delivery of oxygen and
nutrients to the brain, so understanding whether vascular
alterations are a cause or consequence of aspects of AD
pathology, notably Aβ accumulation, is required in order
to design effective therapies.
Amyloid beta peptides, particularly Aβ1–42, are hall-
marks of AD10. These peptides are the result of sequential
proteolytic cleavage of amyloid precursor protein (APP)
by β- and γ-secretase enzyme activity. Whilst it is repor-
ted that synapse loss is the best correlate of clinical out-
come in AD11, it is unclear as to whether pathological
APP processing products drive this effect by a direct
action on neurons, or indirectly such as through aberrant
angiogenesis. Despite widespread interest in the role of
brain vasculature in AD, little is known about how
amyloid-induced vascular changes alter pathological
sprouting angiogenesis.
Sprouting angiogenesis is responsible for the formation
of new blood vessels in the cortex. This process (both
pathological and physiological) encompasses sequential
events including; sprouting at the vascular front of
endothelial cells, extension of sprouts, the formation of
new vascular loops and pericyte recruitment12–14. Pericyte
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recruitment is closely linked to endothelial cell sprouting.
Endothelial tip cells secrete platelet derived growth factor
(PDGF) that activates platelet derived growth factor
receptor beta (PDGFRβ) on pericytes to induce their
migration to the sprout15,16. Endothelial sprouting is
regulated by the NOTCH signalling pathway17. NOTCH
receptors (NOTCH1–4) undergo proteolytic processing
via γ-secretase in a manner comparable to that of APP18,19
resulting in the hypothesis that interactions between these
signalling pathways could underlie the angiogenic
pathology in AD20,21.
Whilst indirect measures of angiogenic activity, such as
vessel density, can be studied in post mortem brains,
active processes, such as ﬁlopodia extension from tip
cells, are notoriously difﬁcult to observe in vivo.
Mechanistic exploration of pathological angiogenesis
using drugs, such as BACE1, is also complicated by issues
of blood–brain barrier penetration and peripheral effects
(such as metabolic changes) that may confound inter-
pretation of results22. To permit mechanistic exploration
of the relationship between amyloid pathology, NOTCH
signalling and pathological angiogenesis, we used orga-
notypic brain slice cultures (OBSCs), which provide an
excellent experimental platform for such studies. OBSCs
initially retain a dense network of capillaries and neuro-
vascular units alongside maintenance of neuronal archi-
tecture and non-neuronal cell populations23–25.
Crucially, OBSCs provide a three-dimensional culture
system that supports the formation of new blood vessels
and are amenable to pharmacological manipulation, live
imaging and repeated measurements without inter-
ference from peripheral systems26–29. We and others
have previously shown that OBSCs are powerful tools for
investigating the progression of AD-like alterations
including Aβ accumulation30, synaptic disruption27,31
and cerebrovascular damage32.
In this study, we ﬁnd evidence for early pathological
angiogenesis in the brains of postnatal TgCRND8 mice
which was recapitulated in OBSCs. In addition to
increased vessel density, OBSCs from TgCRND8 mice
showed an increase in sprouting angiogenesis, that could
be completely blocked by BACE1 inhibition. We investi-
gate the mechanisms by which pathological APP proces-
sing and NOTCH signalling interact to induce excessive
vascular sprouting and discuss the implications for the
blood vessel pathology seen in AD.
Results
TgCRND8 mice show vascular abnormalities in the cortex
Vascular abnormalities have been widely reported in a
range of amyloidosis mouse models, with conﬂicting
reports demonstrating both increased and decreased
microvessel density in adult transgenic mice3,5,33. Here,
we sought to examine whether TgCRND8 mice show
evidence of early pathological angiogenesis, as a potential
reaction to the initiating steps of amyloidosis, where
therapeutic intervention is more likely to be effective. We
studied P7 TgCRND8 mouse post mortem cortex to
determine whether a mutant huAPP transgene (and
associated dysregulated amyloid processing), leads to
pathological changes in the organisation of the vascular
network and endothelial cell physiology during postnatal
development (30,31) (Fig. 1). PECAM-1 (a marker of
endothelial cells) expressing cortical blood vessels of P7
TgCRND8 mice (Fig. 1b, b′’) appeared to be more tor-
tuous than cortical vessels of P7 WT mice (Fig. 1a, a′).
When assessing PDGFRβ+ pericyte coverage of blood
vessels in P7 TgCRND8 cortex, we found an ~2-fold
higher pericyte coverage when compared to WT (Fig. 1c)
with coverage becoming almost complete (Fig. 1b). We
also found a signiﬁcant increase in PECAM-1+ vessel
density (Fig. 1d), with no signiﬁcant alteration in vessel
diameter (Fig. 1e).
Characterisation of sprouting angiogenesis in organotypic
brain slice cultures
We next sought to establish potential mechanisms by
which the presence of a mutant huAPP transgene results
in pathological angiogenesis. For this we required an
experimental system in which key angiogenic processes
could be easily observed and manipulated. We established
an ex vivo cortical organotypic brain slice culture (OBSC)
system to analyse this highly regulated process and found
we were able to identify multiple stages of sprouting
angiogenesis in OBSCs from wild-type (WT) mice
(summarised in Fig. 2e) that were not observable in post
mortem brain (Fig. 1). PECAM-1 staining showed a dense
network of blood vessels expressing basal membrane
protein laminin in 7-days in vitro cortical slices (Fig. 2a).
Endothelial tip cells were found either along the trunk of
PECAM-1+ blood vessels with few ﬁlopodia (Fig. 2b,
asterisk) or at the leading edge of vascular sprouts
extending numerous ﬁlopodia (Fig. 2b, c) indicating active
sprouting angiogenesis. The ﬁlopodia of some vascular
sprouts were also found to engage with those of a nearby
endothelial tip cells to form a bridge and the formation of
new blood vessels (Fig. 2d).
PDGFRβ+ pericytes were found around the OBSC blood
vessels and with long cytoplasmic processes surrounding
the abluminal surface of endothelium (Fig. 3a–c). High
magniﬁcation confocal imaging showed that PDGFRβ
expressing pericytes were closely associated with the
PECAM-1+ vascular sprouts (Fig. 3d, e, framed image)
and astrocytes within neurovascular units (Fig. 3f–h) at
7 days in vitro. Taken together, this demonstrates the
utility of OBSCs as a tool to assess different steps of
sprouting angiogenesis, including ﬁlopodia formation and
pericyte coverage.
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Excessive vascular sprouting is associated with increased
vascular density and number of pericytes in TgCRND8
OBSCs
To determine whether OBSCs recapitulated our in vivo
observations, we next looked for signs of vascular
abnormalities in 7 days in vitro TgCRND8 OBSCs (Fig. 4).
The capillary density (as measured by area of PECAM-1
staining) was signiﬁcantly higher in TgCRND8 OBSCs
compared to cultures from WT littermates (Fig. 4a, b).
PECAM-1+ cells were found to co-localise with Ki67 (a
marker of cell division) (Supplementary Fig. 1), potentially
indicating increased endothelial proliferation as a con-
tributor to increased vascular density. Confocal micro-
scopy also revealed an increase in the number of ﬁlopodia
found both at the leading edge, as well as along the body,
of the vascular sprouts in TgCRND8 cultures (Fig. 4c)
alongside a 50% increase in the number of ﬁlopodia at the
vascular sprout of the blood vessels (Fig. 4d). Interestingly,
OBSCs from an alternative amyloidosis mouse model
(5xFAD) showed similar changes, with a signiﬁcant
increase in PECAM-1+ vessel length and area (Supple-
mentary Fig. 2a–c) and a substantial increase in ﬁlopodia
number (Supplementary Fig. 2d, e) compared to WT lit-
termate controls, indicative of conserved mechanisms
between models.
In 7 days in vitro TgCRND8 OBSCs, the number of
PDGFRβ+ pericytes around the capillaries was sig-
niﬁcantly higher than WT controls (Fig. 5a, b) even when
normalised to the increased density of blood vessels
(Fig. 5c). The increased number of PDGFRβ+ pericytes
was correlated with an upregulation of PDGFRβ protein
expression as measured by western blot (Fig. 5d, e).
Inhibition of BACE1 activity normalises vascular density
and hypersprouting in TgCRND8 OBSCs
To investigate if higher vascular density and ﬁlopodia
number depend on the increased production of Aβ seen
in TgCRND8 OBSCs, we applied the BACE1 inhibitor
Fig. 1 Vascular morphology in the cortex of postnatal TgCRND8 mice. a, b Blood vessels were stained by PECAM-1 and pericytes by PDGFRβ.
Increased pericyte coverage and microvessel tortuosity (arrows and framed areas) is seen in P7 TgCRND8 cortex; scale bar 20 μm. (a′, b′) Enlarged
white-framed areas in a and b showing samples of normal microvessels in WT (a′) and tortuous microvessels (*) in TgCRND8 (b′) cortex; scale bar
10 μm. c There is increased PDGFRβ+ pericyte coverage in TgCRND8 cortex (*p < 0.05). d There is an increase in PECAM-1+ area in TgCRND8 cortex
(*p < 0.05). e No difference in vessel diameter was detected (p > 0.05); mean ± SD (n= 2 (WT), n= 4 (TgCRND8), Student’s t-test.
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LY2886721 to OBSCs for 7 days in vitro (Fig. 6a). This
inhibitor has been extensively characterised both in vivo
and in vitro and found to be a potent and highly selective
BACE inhibitor (with essentially no inhibition of cathe-
psin D, pepsin, renin or other similar aspartyl pro-
teases)34. Using ELISA, we found that BACE1 inhibitor
completely abolished the generation of Aβ1–40 and Aβ1–42
in the TgCRND8 OBSC culture medium (Fig. 6b) in
agreement with previous characterisation of this inhi-
bitor34. Interestingly, Aβ was found to co-localise with
blood vessels in TgCRND8 OBSCs, but was absent in WT
vessels (Supplementary Fig. 3a, b). Vascular Aβ was
completely abolished by BACE1 inhibitor treatment
(Supplementary Fig. 3b). BACE1 inhibition reduced the
vascular density in TgCRND8 slices back to WT levels,
with no additional effect on WT cultures (Fig. 6c–e).
Quantiﬁcation of PECAM-1+ capillaries revealed a
twofold increase in total vessel length in TgCRND8
OBSCs, which was restored to WT levels after BACE1
inhibition (Fig. 6f). Similarly, BACE1 inhibition reduced
the excessive sprouting activity of PECAM-1+ endothe-
lial cells in TgCRND8 OBSCs, signiﬁcantly lowering the
Fig. 2 Characterisation of sprouting angiogenesis in 7-days in vitro organotypic cortical slice cultures from wild-type mice. a Confocal
images of cortical slices stained for PECAM-1 (green) and laminin (red) to visualise blood vessels at 7 days in vitro, scale bar 500 μm. b–d Different
stages of vascular sprouting can be visualised in cortical brain slices including; tip cell formation (*) endothelial tip extension (framed area in b which
is expanded in c) new sprouting (arrow heads) and bridging (arrow) (scale bar 50 μm) (d). e Diagram summarising the different stages of sprouting
angiogenesis that can be observed in cortical organotypic slice cultures.
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number of ﬁlopodia at the leading edge of the vascular
sprout back to WT levels (Fig. 6g–i). Conversely, direct
application of synthetic huAβ1–42 to WT cultures
resulted in a signiﬁcant increase in PECAM-1+ vessel
density and length (Supplementary Fig. 4a–d), further
supporting a hypothesis whereby the overproduction
of Aβ in TgCRND8 tissue can trigger pathological
angiogenesis.
Despite signiﬁcant rescue of hypersprouting (Fig. 6) we
found that BACE1 inhibition did not normalise the
increased levels of PDGFRβ in TgCRND8 OBSCs (Sup-
plementary Fig. 5). Indeed, BACE1 inhibition increases
the levels of PDGFRβ in WT OBSCs, but this is
uncoupled from the lack of change seen in PECAM-1+
vessel coverage, length and ﬁlopodia number (Fig. 6).
BACE1 inhibition restores Notch3 and Jag1 mRNA levels in
TgCRND8 cortical slices
Given that modulating APP/Aβ metabolism via BACE1
inhibition resulted in normalisation of hypersprouting, we
hypothesised that interaction between Aβ peptide pro-
cessing and NOTCH signalling might explain the endo-
thelial hypersprouting observed in TgCRND8 mice. To
test this hypothesis, we examined the mRNA levels of key
components of the NOTCH signalling pathway,
NOTCH1, NOTCH3, JAG1, JAG2 and DLL4, in control
Fig. 3 Pericytes are well preserved in organotypic cortical slices at 7 days in vitro. a–c Confocal images showing PECAM-1+ blood vessels
(green) (a, c) covered by PDGFRβ+ pericytes (red, arrows (a, b)) in 7 days in vitro WT cortical slices; scale bar 20 μm. d Higher magniﬁcation images of
the framed area in a with DAPI counterstain depicting nuclei (grey). Pericytes (arrows) can be seen on the PECAM-1+ angiogenic blood vessels; scale
bar 10 μm. e depicts enlarged area framed in d showing clear vascular sprouting. f–h Confocal z-stacks show a preserved cytoarchitecture, consisting
of PECAM-1+ blood vessels (green), surrounded by PDGFRβ+ pericytes (red) and GFAP+ astrocytes (blue) (DAPI= grey). Arrow marks the close
association between the pericytes and astrocytes; scale bar 20 μm.
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vs. BACE-inhibitor treated TgCRND8 and WT littermate
OBSCs. Real-time quantitative PCR analysis showed that
mRNA levels of Notch3 (Fig. 7a) and Jag1 (Fig. 7b) were
signiﬁcantly lower in TgCRND8 OBSCs when compared
to the WT controls, whilst expression of Notch1, Jag2 and
DLL4 were not signiﬁcantly changed (Fig. 7c–e). In all,
5 μM BACEI inhibitor treatment for 7 days in vitro nor-
malised both Notch3 and Jag1 mRNA expression back to
the levels observed in WT cultures (Fig. 7a, b). We found
no signiﬁcant changes in the mRNA expression of Notch1,
Jag2, DLL4 in TgCRND8 or WT slices after BACE1
inhibitor treatment (Fig. 7c–e). Interestingly, application
of synthetic Aβ to WT slices for 3 days in vitro resulted in
a reduction in Notch3 mRNA (Supplementary Fig. 4e) but
did not alter the levels of Jag1 mRNA (Supplementary
Fig. 4f), potentially indicating that changes to Notch3 are
upstream to alterations in Jag1.
BACE1 inhibition induces cleavage of NOTCH3 intracellular
domain (NICD3) in TgCRND8 cortical slices
Finally, we analysed how higher production of Aβ
affects NOTCH3 and NOTCH1 signalling activity in
TgCRND8 OBSCs (Fig. 7f–i). Translocation of the
NOTCH intracellular domain (NICD) into the nucleus is
a negative regulator of endothelial sprouting17, so we
tested whether the reduction in Notch3 mRNA led to
lower levels of NICD3. Western blot analysis showed a
trend for reduced levels of NOTCH3 intracellular domain
(NICD3) in TgCRND8 cortical slices (Fig. 7f, g). In con-
trast, BACE1 inhibitor treatment signiﬁcantly increased
NICD3 levels in TgCRND8 slices to at least the level of
WT cortical cultures (Fig. 7f, g). Consistent with the
mRNA levels of Notch1, there was no effect of genotype or
BACE1 inhibition on the appearance of NOTCH1 intra-
cellular domain (NICD1) (Fig. 7h, i).
Discussion
In this study, we explored the relationship between Aβ
processing, NOTCH signalling and pathological angio-
genesis in cortical tissue from huAPP transgenic mice. We
report that BACE1 inhibition can reverse the increased
pathological angiogenesis observed in TgCRND8 OBSCs
alongside restoration of NOTCH signalling. We ﬁnd that
pathological angiogenesis is an early event in TgCRND8
mice, and is detectable before amyloid plaque formation,
synapse loss or cognitive deﬁcits35. Restoration of phy-
siological levels of angiogenesis early in the disease course
may therefore be an important target for AD therapeutics.
This study took advantage of the OBSC system to
explore mechanisms of pathological angiogenesis that are
difﬁcult to study in vivo. OBSCs are a potent, underused
tool for exploring vascular phenotypes23,36,37 with few
prior studies seeking to explore this in combination with
AD models32,38. Interestingly, the increased sprouting
angiogenesis we observed in TgCRND8 OBSCs is more
pronounced than we ﬁnd in vivo at a similar age. The
OBSC method likely stresses the tissue via the slicing
injury and/or the isolation from the systemic vasculature;
stimulating sprouting angiogenesis. By allowing visuali-
sation of such processes in both WT and TgCRND8 tis-
sue, the OBSC system appears to unmask a mechanism
that underlies the vascular changes in AD models that
may otherwise be overlooked.
Our ﬁnding that tissue from postnatal TgCRND8 mice
shows pathological angiogenesis is of interest in the
context of aging being a major risk factor for AD. Studies
examining human brain microvessel density in the con-
text of “normal” ageing have revealed inconsistent results
(increased/decreased/no change) in aged vs. young indi-
viduals depending on brain region and microvessel type
studied39–42. Despite widespread interest in vascular
pathology in AD, there is also debate as to the relative
roles of pro- and anti- angiogenic processes during dis-
ease progression1. For example, whilst some studies
demonstrate increased angiogenesis in post mortem
human AD or huAPP-mouse brain3,5,6,43, others report
endothelial cell apoptosis and loss of vasculature33,44. It
seems likely that such studies represent different stages of
disease, with initial increases in angiogenesis (potentially
as a result of rising Aβ that occurs in ageing45,46) being
overtaken by cell death in the end stages1. Clearly, more
work is required to fully understand the complex rela-
tionships between age, AD and vascular pathology,
although our work indicates pathological angiogenesis can
be induced by dysregulated Aβ processing even in the
absence of ageing.
A potential role for Aβ as a regulator of angiogenesis
has been previously proposed from observations in both
physiological and pathological conditions. In post mortem
human AD brains, it has been shown that increased vas-
cular density in the hippocampus6 and pericyte-mediated
capillary restriction47 correlates with Aβ load. In amyloid
mouse models, immunisation with Aβ peptides cleared
plaques and restored capillary density to normal levels48
whilst inhibition of Aβ aggregation reduced arteriolar Aβ
accumulation and tortuosity7. Application of synthetic Aβ
to a number of models has also highlighted its pro-
angiogenic role with increased endothelial cell prolifera-
tion, capillary bed density and vascular sprouting seen
both in vitro and in vivo20,49,50. Our use of a novel OBSC
platform that endogenously expresses mutant APP with
all its processing products allows for careful exploration
of the effects of Aβ as well as other APP-derived products
on vascular pathology51–53. Our ﬁndings add weight to
growing evidence that dysregulation of amyloid proces-
sing, or exogenously applied huAβ1–42 (Supplementary
Fig. 4), can stimulate pathological angiogenesis. It is worth
noting, that whilst we were unable to analyse the exact
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form (monomeric, oligomeric etc.) of Aβ present in the
TgCRND8 cultures (due to the presence of serum in the
culture medium and very low concentration in the slice
tissue itself) we know from our previous work that the Aβ
present, and thus likely responsible for our observed
phenotypes, is soluble, thioﬂavin-S negative and is not
sequestered in extracellular plaques27.
A key ﬁnding in this study is that overproduction of Aβ
in TgCRND8 OBSCs is accompanied by reduced
expression of the angiogenesis suppressor NOTCH3 and
its ligand JAG1, providing a novel mechanistic insight into
how amyloid pathology potentially impacts angiogenesis
in AD. Previous studies have shown that Notch3 knockout
increases retinal vascular density and endothelial tip for-
mation54 and silencing NOTCH3 in tumours promotes
pathological angiogenesis55. NOTCH ligand JAG1 has
also been implicated in angiogenic processes, with Jag1
targeting antisense oligonucleotides potentiating FGF-
responsive tube formation and invasion in vitro56. There
are multiple potential mechanisms by which Notch3 and
Jag1 could be downregulated in postnatal TgCRND8 tis-
sue, which we summarise in our working hypothesis
(Fig. 8).
NOTCH proteins and NOTCH ligands are substrates
for the γ-secretase presenilin57, resulting in the pro-
duction of NICD which translocates to the nucleus to
regulate gene expression (Fig. 8a). Cleavage of NOTCH3
by γ-secretase has been found to induce Notch3 and Jag1
transcription via autoregulatory mechanisms58. Previous
work has also shown that NOTCH3 activation (by
cleavage to NICD3) is prevented by treatment with γ-
secretase inhibitors59 which results in increased angio-
genic sprouting60. Interestingly, this effect is mimicked
by the application of synthetic monomeric Aβ potentially
pointing to an enzymatic feedback inhibition, whereby
high levels of Aβ lower the activity of γ-secretase49. This
study aligns with our ﬁndings that application of syn-
thetic Aβ to WT OBSCs results in increased microvessel
density alongside a reduction in Notch3 mRNA (Sup-
plementary Fig. 4). In TgCRND8 tissue (Fig. 8b)
increased levels of Aβ may act via this mechanism to
inhibit the efﬁcacy of γ-secretase, reducing levels of
NOTCH3 cleavage and so lowering Notch3 and Jag1
transcription, ultimately resulting in increased sprouting
angiogenesis. Alternatively, other APP processing pro-
ducts may also have inhibitory effects on γ-secretase.
β-CTF, the result of BACE1 cleavage of APP, contains a
region (Aβ17–23) that has been found to modulate
γ-secretase activity by non-competitive inhibition61 and
a similar role has been proposed for the APP intracel-
lular domain (AID)19. Alternatively, increased expression
of APP, or enhanced processing of APP through
γ-secretase may directly compete with NOTCH ligands
for enzymatic availability62.
Fig. 4 TgCRND8 organotypic cortical slices show increased vascular density and excessive ﬁlopodia formation when compared to wild-
type cultures. a Representative confocal images showing blood vessel density (PECAM-1, green) in 7 days in vitro WT and TgCRND8 slices; scale bar
100 μm. b Quantiﬁcation of PECAM-1+ area (as percentage of the total image) reveals a signiﬁcantly higher blood vessel density in TgCRND8 cortical
slices vs. WT slices. (mean ± SD (n= 5 (WT), n= 4 (TgCRND8), *P < 0.05 Student’s t-test). c Confocal images showing endothelial cells extending
numerous ﬁnger-like ﬁlopodia at the forefront of vascular sprouts in 7 days in vitro WT and TgCRND8 cortical slices, visualised by PECAM-1 labelling.
Red dots highlight vascular sprouting tips, scale bar 20 μm. d Quantiﬁcation shows that the number of ﬁlopodia per cell is signiﬁcantly higher in
TgCRND8 when compared to WT slices. (mean ± SD, (n= 14 (WT), n= 13 (TgCRND8), *P < 0.05 Student’s t-test).
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In this study, we ﬁnd that excessive endothelial ﬁlopodia
formation and reduced NOTCH3/JAG1 signalling in
TgCRND8 OBSCs can be normalised via application of
BACE1 inhibitor (Fig. 8b) indicating a likely role for
BACE1-dependent APP processing products. Interest-
ingly, PDGFRβ protein remained elevated in BACE1-
inhibitor treated TgCRND8 cultures and such treatment
increased PDGFRβ in WT cultures (Supplementary
Fig. 5), without impacting vascular phenotypes (Fig. 6).
The role of pericytes in angiogenesis is dynamic and at
times opposing63, with contrasting studies demonstrating
their presence promotes early angiogenesis and vessel
survival13,64–66, whilst inhibiting endothelial cell pro-
liferation or inducing vessel regression in later stages67–69.
This raises the possibility that increased pericyte expres-
sion could be a compensatory attempt at terminating
pathological angiogenesis in TgCRND8 cultures which
only becomes effective after normalisation of Aβ levels.
BACE1 treatment in WT cultures may end ongoing
physiological angiogenesis, resulting in the proliferation of
pericytes on the stabilised, mature vessels. Alternatively,
BACE1 may have an independent role in regulating
PDGFRβ signalling that is uncoupled, at least in the short-
term, from alterations in endothelial ﬁlopodia or micro-
vessel density. BACE1 inhibitors have previously been
shown to inhibit angiogenesis and tumour growth70.
BACE1 knockout mice show reduced vascular density71
and treatment of zebraﬁsh with BACE1 inhibitors was
found to induce similar deﬁcits, with application of Aβ
restoring normal vascularisation72. Whilst we hypothesise
that the normalisation of TgCRND8 angiogenesis after
BACE1 inhibition is due to reduced levels of Aβ, we have
to consider the possibility that BACE inhibition has a
direct effect on angiogenic processes unrelated to APP.
Other studies have found that BACE1 directly regulates
JAG1 shedding, with BACE1−/−mice showing an increase
in Jag1 levels and downstream NOTCH signalling73. This
seems an unlikely mechanism in our system, however, due
to the observation that BACE1 inhibition has no effect on
the levels of Jag1 (Fig. 7b) or vascular density (Fig. 6) in
WT OBSCs and that application of synthetic Aβ alone
increases PECAM-1+ vessel density (Supplementary Fig. 4).
Fig. 5 Increased pericyte number and PDGFRβ expression in TgCRND8 organotypic cortical slices. a Representative confocal images showing
PDGFRβ+ pericytes (arrows) around blood vessels (PECAM-1, green) in 7 days in vitro WT and TgCRND8 slices; scale bar 50 μm. PDGFRβ+ pericytes
are closely associated with cortical microvessels. a′ The framed areas in a are enlarged, scale bar 50 μm. b Quantiﬁcation of PDGFRβ+ pericytes
reveals an increased number in 7 days in vitro TgCRND8 slices when compared to WT (data are expressed as cell numbers per mm3. c Quantiﬁcation
of PDGFRβ+ staining area normalised to PECAM-1+ staining area shows a signiﬁcant increase in pericyte coverage in TgCRND8 OBSCs; mean ± SD.
(n= 4 (WT), n= 5 (TgCRND8), *P < 0.05 Student’s t-test). Representative western blots (d) and quantiﬁcation of PDGFRβ band intensity (e) in 7 days
in vitro WT and TgCRND8 cortical slices, shows increased PDGFRβ in TgCRND8 cultures when normalised to Actin control (n= 5 (WT), n= 4
(TgCRND8) **P < 0.01 Student’s t-test).
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From our results, however, it is possible that BACE1
plays an independent role in pericyte recruitment/
PDGFRβ expression, which warrants further exploration.
Future studies could also examine whether the rescue
effect of BACE1 inhibition on pathological angiogenesis
is reversible, providing greater insight into the dynamics
of angiogenesis in response to changes in amyloid
processing.
Further mechanistic studies are needed to better
understand the interplay between NOTCH signalling and
Fig. 6 BACE1 inhibition decreases vascular density and normalises aberrant vascular sprouting in TgCRND8 organotypic cortical slices.
a Diagram showing the experimental schedule for BACE1 inhibitor treatment of WT and TgCRND8 cortical slices. b Measurement of Aβ1–40 and
Aβ1–42 in the culture medium of 7 day in vitro TgCRND8 slices treated with BACE1 inhibitor (mean ± SEM (n= 4), two-way ANOVA effect of treatment
****P < 0.0001). c Confocal images showing blood vessel density (PECAM-1, green) in 7 days in vitro control (c) and BACE1 inhibitor (c′) treated WT
slices. d–d´ Confocal images showing blood vessel density (PECAM-1, green) in 7 days in vitro control (d) and BACE1 inhibitor (d′) treated
TgCRND8 slices; scale bar 20 μm. BACE1 inhibition rescues the increase in PECAM1+ area (percentage image coverage) (mean ± SD (n= 4 (WT), n= 4
(TgCRND8), *P<0.05, two-way ANOVA) (e) and total vessel length (mm/mm2) (mean ± SD (n= 4 (WT), n= 4 (TgCRND8), **P<0.01 and *P < 0.05, two-
way ANOVA) (f) seen in control treated TgCRND8 cultures. PECAM-1 staining of WT (g–g′) and TgCRND8 (h–h′) slice cultures with (g′, h′) or without
(g, h) BACE1 inhibitor treatment. Individual ﬁlopodia are highlighted with red dots. i Quantiﬁcation of the number of ﬁlopodia per cell demonstrates
that BACE1 inhibitor rescues the increased number seen in untreated TgCRND8 cultures when compared to WT at 7 days in vitro (mean ± SD, (n= 4
(WT), n= 4 (TgCRND8), ****P<0.0001, two-way ANOVA).
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Fig. 7 NOTCH signalling in BACE1-treated organotypic cortical slices. a–e Quantitative gene expression analysis of NOTCH receptors (Notch1
and -3) and NOTCH ligands (Dll4, Jag1, Jag2) in 7 days in vitro WT and TgCRND8 OBSCs treated with BACE1 inhibitor. Untreated TgCRND8 OBSCs
show a signiﬁcant reduction in the levels of Notch3 (a) and Jag1 (b) compared to WT cultures. BACE1 inhibitor treatment normalised the expression
levels of Notch3 (a) and Jag1 (b) in TgCRND8 cortical slices (mean ± SD, n= 5 (WT), n= 6 (TgCRND8), *P<0.05 and **P<0.01, two-way ANOVA). BACE1
inhibitor treatment had no effect on the expression of Notch1 (c), Jag2 (d) and DLL4 (e) in 7 days in vitro TgCRND8 or WT cortical slices, (mean ± SD,
n= 5 (WT), n= 6 (TgCRND8), P > 0.05, two-way ANOVA). f, g Representative western blots and quantiﬁcation of NOTCH3 intracellular domain (NICD3)
in 7 days in vitro WT and TgCRND8 cortical slices treated with BACE1 inhibitor. (Data expressed in band intensity; mean ± SD, *P<0.05, n= 4 (WT), n=
12 (TgCRND8), two-way ANOVA, Tukey post-hoc test.) h, i Representative western blots and quantiﬁcation of Notch1 intracellular domain (NICD1) in
7 days in vitro WT and TgCRND8 cortical slices treated with BACE1 inhibitor (Data expressed in band intensity; mean ± SD, n= 9 (WT), n= 14
(TgCRND8), P > 0.05, two-way ANOVA).
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APP processing mechanisms in AD. Here, we propose
that APP overexpression or feedback inhibition from high
Aβ/ β-CTF concentration in TgCRND8 OBSCs reduces
γ-secretase-dependent cleavage of NOTCH3 (Fig. 8). Our
results also indicate that there may be a safe level of
BACE1 inhibition that can restore physiological levels of
angiogenesis, without inducing angiogenic deﬁcits in
healthy tissue.
Methods
Mice
TgCRND8 mice35 were maintained on a mixed BL6:
sv129 background. TgCRND8 mice overexpress human
APP with both the Swedish (K670N/M671L) and Indiana
(V717F) mutations. 5xFAD mice74 were maintained on a
C57BL/6 x SJL background. 5xFAD mice express human
APP with the Swedish (K670N/M671L), Florida (I716V)
and London (V717I) mutations, alongside human PSEN1
with the M146L and L286V mutations. TgCRND8 or
5xFAD heterozygote males were bred with wild-type
background matched females to produce both wild-type
and transgenic heterozygote littermates. Animals were kept
on a 12 h:12 h light:dark cycle at a constant temperature of
19 °C in a pathogen-free environment. All animal work was
approved by the Babraham Institute Animal Welfare and
Ethical Review Body, the University of Cambridge and the
UK Home Ofﬁce, and carried out in accordance with the
Animals (Scientiﬁc Procedures) Act, 1986.
Organotypic brain slice cultures
Cortical organotypic brain slice cultures were made from
humanely killed P6–P9 littermates of either sex according
to the method of de Simoni et al and our previous
work27,31,75. Brieﬂy, after schedule 1, brains were kept on
ice in dissection buffer (EBSS supplemented with 25mM
HEPES and 1x Penicillin/Streptomycin). In all, 350-μm-
thick sagittal sections of cortex were cut using a Leica
VT1000S vibratome and slices collected using a modiﬁed
sterile 3 ml Pasteur pipette. On average 6 cortical slices
were collected per pup and stored in dissection buffer on
ice until plating. For long-term culture, slices were trans-
ferred, in a class II hood, onto sterile Millicell® membrane
inserts (Millipore PICM0RG50) in 35mm culture dishes
(Nunc). 3 cortical slices from the same pup were plated to
a single membrane, with two dishes made per animal.
Inserts were maintained in 1ml of maintenance medium
according to the following recipe: 50% MEM with
Glutamax-1 (Life Technologies 42360–024), 25% Heat-
inactivated horse serum (Life Technologies: 26050–070),
23% EBSS (Life Technologies: 24010–043), 0.65% D-
Glucose (Sigma:G8270), 2% Penicillin/Streptomycin (Life
Technologies 15140–122) and 6 units/ml Nystatin (Sigma
N1638). Membrane inserts were handled with sterile for-
ceps and the medium was changed 100% 4 h after plating
and at 4 div. OBSCs were maintained at 37 °C, 5% CO2 and
high humidity for 7 div. For BACE1 inhibition experi-
ments, 1 culture per pup was treated with 5 µM BACE1
inhibitor LY2886721 (Selleckchem S2156) (previously
reported to have high potency and speciﬁcity both in vivo
and in vitro34) and compared with a DMSO treated con-
trol from the same animal. Cultures were treated for the
entire 7 days in vitro. Synthetic huAβ1–42 was prepared
according to a previously published protocol76 (see sup-
plementary methods).
Fig. 8 Proposed mechanism for the enhancement of sprouting angiogenesis by BACE1-dependent APP processing. Schematic diagram of
our working hypothesis for increased sprouting angiogenesis in TgCRND8 (b) compared to WT (a) tissue. Increased APP processing by BACE1 in
TgCRND8 OBSCs competes with NOTCH3 for γ -secretase or reduces γ-secretase activity, thereby lowering transcriptional signalling through NICD.
This reduces Notch3-Jag1 expression via autoregulatory mechanisms, thereby releasing the inhibitory inﬂuence on sprouting angiogenesis. Created
with BioRender.
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Immunohistochemistry
OBSCs
OBSCs were ﬁxed for 20 min in 4% PFA in phosphate
buffered saline (PBS), washed three times in PBS, then
blocked for 1 h in PBS supplemented with 0.5% Triton
X-100 and 3% normal Goat Serum (Sigma G9023). Slices
were incubated at 4 °C in primary antibody (diluted in
blocking solution) overnight. In order to detect PDGFRβ,
heat-mediated antigen retrieval was performed in 10mM
citrate buffer (pH 6.0) for 40 min at 80 °C prior to primary
antibody incubation. Slices were washed a further three
times in 0.5% Triton-X100 in PBS (PBS-TX) then incu-
bated with secondary antibodies (Life Technologies and
Jackson) (1:500 dilution in blocking solution for 2 h at
4 °C). Three ﬁnal PBS-TX washes were conducted before
slices were mounted on slides and images captured using
a Leica Confocal Microscope. Primary antibodies used:
rabbit anti-PDGFRβ (28E1) (1:200, Cell Signalling, Cat.
No: 3169S), rat anti-PECAM-1 (1:400, BD, Cat. No:
550274), rabbit anti-laminin (1:200, Sigma, Cat. No:
L9393), Mouse MOAB-2 (pan Aβ) (1:1000, Merck-Milli-
pore, Cat. No: MABN254) Rabbit Ki67 (1:1000, Abcam,
Cat. No: ab15580) secondary staining was conducted
using species-speciﬁc ﬂuorophore-conjugated (Streptavi-
din Alexa 488, Molecular Probes; Cy3 or Cy5, Jackson,) or
biotin-conjugated secondary antibodies (Jackson). DAPI
(1 μg/mL, Sigma) was used to counterstain nuclei.
Cryosections of postnatal mouse brain
P7 WT and TgCRND8 pups, of either sex were culled
via cervical dislocation followed by decapitation. Brains
were removed, snap-frozen, and embedded in Tissue-
Tek® OCT compound (Sakura Finetek, The Netherlands).
Cryosections were cut at 20 μm thickness and ﬁxed in
either ice cold acetone or 2% PFA for 20 min and air-
dried. Cryosections were then stained for PECAM-1 and
PDGFRβ as described above.
Microscopy and image analysis
Images were captured via an epiﬂuorescence micro-
scopy system (Leica DM6000B) or using confocal
microscopes (Leica, Zeiss LSM780). Figures were com-
posed using Photoshop CS5 software. All analysis was
done blind to genotype and/or treatment condition.
Quantiﬁcation of pericyte number and coverage
To quantify the number of PDGFRβ-positive pericytes,
cells were counted using NIH Image J Cell Counter tool.
A maximum projection of ﬁfteen-micrometre z-stacks
was acquired from cortex slices freshly derived from WT
and TgCRND8. Three pictures were taken at 40x for each
slice. The areas of PDGFRβ+ pericytes and PECAM-1+
blood vessels were separately subjected to threshold
processing and the respective signals for each image was
calculated using NIH Image J Area Measurement tool.
Pericyte coverage was determined as a percentage (%) of
PDGFRβ+ pericyte area covering PECAM-1+ capillary
surface area per ﬁeld (ROI) 733 × 733 μm. Three slices per
animal were analysed.
Capillary density, length and ﬁlopodia quantiﬁcation
For PECAM-1+ capillary area, sections were analysed
with Leica confocal microscope. Three pictures were
taken at 20x for each section. ROI size of 733 × 733 μm
for confocal images were utilised. The area covered by
PECAM-1+ capillaries was analysed using the NIH
ImageJ area measurement tool where pictures were
subjected to threshold processing to produce a binary
image. The area of PECAM-1 coverage was expressed as
percentage of the total area, three slices per WT and
TgCRND8 pups (n= 4–5 for each genotype) were ana-
lysed. The ﬁlopodia of vascular sprouts were analysed
using z-stacked PECAM-1+ blood vessels.
Protein extraction and western Blot
OBSCs were scraped off the membrane insert using a
scalpel and transferred to 2x Laemelli buffer supple-
mented with 10% 2-mercaptethanol (50 µL per three sli-
ces). Samples were boiled for 10 min then frozen at
−20 °C until use. Ten micrograms of protein were sepa-
rated on a 10% SDS polyacrylamide gel then transferred
onto PVDF membranes. Membranes underwent blocking
(20 mM Tris, 136mM NaCl, pH 7.6, 0.1% Tween 20 and
5% nonfat dry milk) before incubation with primary
antibody anti-NOTCH1/NICD1 (1:750, Abcam, Cat No:
ab3294), NOTCH3/NICD3 (1:1000, Abcam, Cat No:
ab23426), PDGFRβ (28E1), (1:1000, Cell Signaling, Cat
No: 3169 S), overnight at 4 °C. overnight at 4 °C. Signals
were obtained by binding of a secondary anti-rabbit horse
radish peroxidase (HRP) linked antibody (1:15000, Sigma-
Aldrich, Cat No: A0545) and visualised by exposing the
membrane to a charge-coupled device camera (LAS1000,
Fujiﬁlm, Tokyo, Japan) using a chemiluminescence kit
(Merck Millipore, Billerica, MA, USA). Membranes were
stripped and reprobed for β-actin (diluted 1:50 000,
Sigma-Aldrich, Cat No: A3854). After densitometric
analysis using Image J software, protein levels were cal-
culated as percentage of β-actin expression.
Aβ ELISA
Culture medium from 7 div OBSCs was assayed for
human Aβ1–40 and Aβ1–42 using commercially available
ELISA kits (Life Technologies: KHB3441 and KHB3481).
Brieﬂy, medium was incubated with Aβ detection anti-
body for 3 h, washed, and then incubated with an HRP-
conjugated antibody for 30min. After another wash step,
stabilised chromogen was added for 30 min before the
adding an acid-based stop solution. Absorbance was read
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at 450 nm using a PheraStar ELISA plate reader with the
standard curve calculated using a 4-parameter ﬁt. Con-
centration of Aβ in the medium is expressed as pg/ml.
Levels of Aβ were compared between BACE1-treated and
DMSO treated TgCRND8 cultures.
Quantiﬁcation of gene expression by qPCR
Slice cultures were scraped off the membrane and RNA
extracted using an RNeasy mini kit (Qiagen). Brieﬂy, three
slices were homogenised in 350 µL lysis buffer RLT sup-
plemented with 1% 2-mercaptethanol. In all, 350 μL 70%
ethanol (in nuclease free water) was then added and
samples transferred to RNeasy RNA collection columns.
After several wash steps described in the kit protocol, the
RNA was eluted in 20 µL nuclease free water, measured
and quality tested using a Nanodrop® and frozen at
−80 °C until use. cDNA synthesis was performed using
Script™cDNA Synthesis Kit (Bio-Rad). cDNA was ana-
lysed using real-time PCR SsoAdvanced™ SYBR® Green
Supermix from Bio-Rad and run on a Bio-Rad CFX96
real-time quantitative PCR (qPCR) system. Gene expres-
sion was normalised to the housekeeping gene GAPDH.
Melt curve analyses were performed to ensure the speci-
ﬁcity of qPCR product. Primer sequences are given in
Supplementary Table 1. Values are presented as mean ±
SD of three independent experiments, and within each
experiment, triplicate samples were assessed.
Statistical analysis
Experimental sample sizes were selected via power
analysis of preliminary data using an online calculator:
http://powerandsamplesize.com. All samples from the
same animal, under the same treatment conditions were
averaged to produce a single biological replicate. Each
experiment was performed on 2–3 independent occa-
sions. Statistical analysis was conducted using Graph Pad
Prism. Data are expressed as mean ± SD. Two group
comparison was performed by using Student’s t-test (two-
sided) and multiple group comparison by one-way or two-
way ANOVA followed by Tukey post-hoc test (to correct
for multiple comparisons). For Western blot, after nor-
malisation to the actin signal, the expression of each
protein was compared using a two-way ANOVA, followed
by Tukey post hoc test. Signiﬁcance was set at p < 0.05.
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